• OPEN AN ACCOUNT
Indian Indices
Sensex
74,781.76 -120.83
( -0.16%)
Global Indices
Nasdaq
52,596.82 511.72
(0.98%)
Dow Jones
7,678.62 65.92
(0.87%)
Hang Seng
63,517.44 -493.90
(-0.77%)
Nikkei 225
10,650.44 41.52
(0.39%)
Forex
USD-INR
95.45 0.39
(0.41%)
EUR-INR
110.95 0.35
(0.32%)
GBP-INR
129.16 0.36
(0.28%)
JPY-INR
0.62 0.00
(0.09%)

EQUITY - MARKET SCREENER

Medicamen Organics Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
92885
INE0PE401018
25.74288
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MEDIORG
0
35.64
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

izmo ltd
Nirlon standalone net profit rises 31.85% in the March 2026 quarter
May 25,2026
Net profit of Nirlon rose 31.85% to Rs 70.59 crore in the quarter ended March 2026 as against Rs 53.54 crore during the previous quarter ended March 2025. Sales rose 8.18% to Rs 170.94 crore in the quarter ended March 2026 as against Rs 158.02 crore during the previous quarter ended March 2025.

For the full year,net profit rose 58.57% to Rs 345.98 crore in the year ended March 2026 as against Rs 218.19 crore during the previous year ended March 2025. Sales rose 5.20% to Rs 669.17 crore in the year ended March 2026 as against Rs 636.07 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales170.94158.02 8 669.17636.07 5
OPM %77.4277.84 -77.8979.06 -
PBDT109.7397.37 13 427.53394.74 8
PBT95.5583.91 14 371.95338.41 10
NP70.5953.54 32 345.98218.19 59